Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients

Recruiting now · Not applicable

Conditions studied: Alcohol-related Liver Disease, Liver Diseases

In brief

The purpose of this trial is to see if providing patients with alcohol-related liver disease with tailored alcohol use treatment options will increase engagement with treatment and correct possible misconceptions.

Key facts

Study ID

NCT06269510

Run by

Henry Ford Health System

People needed

268

Starts

2026-01-28

Expected to finish

2030-02-01

Last updated by the study team

2026-02-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Willingness to comply with all study procedures and availability for the duration of the study
• Willing and able to provide informed consent
• Enrolled at University of Michigan (UM) hepatology clinics or inpatients at UM Hospitals
• Documented diagnosis of alcohol-related liver disease (ALD) (per protocol)
• Recent alcohol use of any amount within the past 6 months as assessed by either patient interview, medical chart review, or positive alcohol biomarker (e.g. blood alcohol level, urinary ethyl glucuronide, urinary ethyl sulfate, or phosphatidylethanol) in the medical record.
• No alcohol use treatment within the past 1 month including, but not limited to:
• Any professionally lead therapy with a mental health counselor (such as, one-on-one therapy, group therapy, couples or family therapy) with a primary aim of alcohol abstinence or reduction in alcohol use.
• Community-based alcohol recovery groups (such as, Alcoholics Anonymous, SMART Recovery, Celebrate Recovery, Refuge Recovery)
• Community-based church support groups primarily focused on alcohol abstinence or reduction in use.
• Residential (inpatient) alcohol treatment
• Intensive outpatient programs
• Any telehealth version of the above options
• Access to a Smartphone or computer for purposes of follow-up. Those who do not have a Smartphone will be provided one along with a calling/data plan at no cost to subject by the study team for the duration of the research stud.
• Ability to speak and comprehend English

You may not qualify if…

• Unable to provide voluntary informed consent for any reason
• Substantially cognitively impaired as evidenced by Westhaven grade 2 or higher hepatic encephalopathy or a score >=10 on the Short Blessed Test for cognitive impairment.
• Unable to read or understand English
• Undergoing active evaluation for liver transplantation, is listed for liver transplant, or is post-transplantation
• Is enrolled in the multidisciplinary ALD clinic at Michigan Medicine
• Any other medical condition or circumstance that precludes safe and meaningful participation in the study
• History of nonadherence to previous clinical or research studies

Where it is running

• Henry Ford Health — Detroit, Michigan, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.